September 08, 2021 03:10 AM Eastern Daylight Time
BUSINESS WIRE
Riassunto: Novaremed espande la sua pipeline di candidati farmaci non oppiacei per indicazioni di dolore cronico rilevando Metys Pharmaceuticals
Tweet
View Full Size
Download
Full Size
JPEG
,
781
x
210
,
31.2 KB
Small
JPEG
,
480
x
129
,
16.1 KB
Preview
JPEG
,
144
x
39
,
3.6 KB
Thumbnail
JPEG
,
120
x
32
,
2.8 KB
Smart Multimedia Gallery
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
All News
|
News with Multimedia
>
Press Release: Riassunto: Novaremed espande la sua pipeline di...